Canine lymphoma as a comparative model for human non-Hodgkin lymphoma

Recent progress and applications

Daisuke Ito, Aric M. Frantz, Jaime F. Modiano

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The term "lymphoma" describes a heterogeneous group of disorders involving monoclonal proliferation of malignant lymphocytes. As a group, lymphomas are among the most common tumors of dogs. Yet our enumeration and understanding of the many subtypes of lymphoma have been relatively slow, perhaps in part because for many years lymphoma was treated as a singular entity rather than a group of distinct diseases. The recognition that the full spectrum of lymphoid malignancies seen in humans also occurs in dogs, and that these tumors retain not only morphologic similarities and biological behavior but also synonymous driver molecular abnormalities, sets an ideal stage for dual-purpose research that can accelerate progress for these diseases in both species. Specifically, dogs represent exceptional models for defining causality, understanding progression, and developing new treatments for lymphoma in comparatively brief windows of time. Unique advantages of canine models include (1) spontaneous disease occurring without an isogenic background or genetic engineering ; (2) chronology of disease adapted to lifespan, (3) shared environment and societal status that allows dogs to be treated as "patients," while at the same time being able to ethically explore translational innovations that are not possible in human subjects; and (4) organization of dogs into breeds with relatively homogeneous genetic backgrounds and distinct predisposition for lymphomas. Here, we will review recent studies describing intrinsic and extrinsic factors that contribute to the pathogenesis of canine and human lymphomas, as well as newly developed tools that will enhance the fidelity of these models to improve diagnosis and develop new treatments.

Original languageEnglish (US)
Pages (from-to)192-201
Number of pages10
JournalVeterinary Immunology and Immunopathology
Volume159
Issue number3-4
DOIs
StatePublished - Jan 1 2014

Fingerprint

non-Hodgkin lymphoma
lymphoma
Non-Hodgkin's Lymphoma
Canidae
Lymphoma
dogs
Dogs
Chronology
Neoplasms
Intrinsic Factor
neoplasms
Genetic Engineering
dog breeds
genetic engineering
Causality
genetic background
lymphocytes
pathogenesis
Lymphocytes
Therapeutics

Cite this

Canine lymphoma as a comparative model for human non-Hodgkin lymphoma : Recent progress and applications. / Ito, Daisuke; Frantz, Aric M.; Modiano, Jaime F.

In: Veterinary Immunology and Immunopathology, Vol. 159, No. 3-4, 01.01.2014, p. 192-201.

Research output: Contribution to journalArticle

@article{75c2c1615de84c538c5685d1a4e27277,
title = "Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: Recent progress and applications",
abstract = "The term {"}lymphoma{"} describes a heterogeneous group of disorders involving monoclonal proliferation of malignant lymphocytes. As a group, lymphomas are among the most common tumors of dogs. Yet our enumeration and understanding of the many subtypes of lymphoma have been relatively slow, perhaps in part because for many years lymphoma was treated as a singular entity rather than a group of distinct diseases. The recognition that the full spectrum of lymphoid malignancies seen in humans also occurs in dogs, and that these tumors retain not only morphologic similarities and biological behavior but also synonymous driver molecular abnormalities, sets an ideal stage for dual-purpose research that can accelerate progress for these diseases in both species. Specifically, dogs represent exceptional models for defining causality, understanding progression, and developing new treatments for lymphoma in comparatively brief windows of time. Unique advantages of canine models include (1) spontaneous disease occurring without an isogenic background or genetic engineering ; (2) chronology of disease adapted to lifespan, (3) shared environment and societal status that allows dogs to be treated as {"}patients,{"} while at the same time being able to ethically explore translational innovations that are not possible in human subjects; and (4) organization of dogs into breeds with relatively homogeneous genetic backgrounds and distinct predisposition for lymphomas. Here, we will review recent studies describing intrinsic and extrinsic factors that contribute to the pathogenesis of canine and human lymphomas, as well as newly developed tools that will enhance the fidelity of these models to improve diagnosis and develop new treatments.",
author = "Daisuke Ito and Frantz, {Aric M.} and Modiano, {Jaime F.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.vetimm.2014.02.016",
language = "English (US)",
volume = "159",
pages = "192--201",
journal = "Veterinary Immunology and Immunopathology",
issn = "0165-2427",
publisher = "Elsevier",
number = "3-4",

}

TY - JOUR

T1 - Canine lymphoma as a comparative model for human non-Hodgkin lymphoma

T2 - Recent progress and applications

AU - Ito, Daisuke

AU - Frantz, Aric M.

AU - Modiano, Jaime F.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The term "lymphoma" describes a heterogeneous group of disorders involving monoclonal proliferation of malignant lymphocytes. As a group, lymphomas are among the most common tumors of dogs. Yet our enumeration and understanding of the many subtypes of lymphoma have been relatively slow, perhaps in part because for many years lymphoma was treated as a singular entity rather than a group of distinct diseases. The recognition that the full spectrum of lymphoid malignancies seen in humans also occurs in dogs, and that these tumors retain not only morphologic similarities and biological behavior but also synonymous driver molecular abnormalities, sets an ideal stage for dual-purpose research that can accelerate progress for these diseases in both species. Specifically, dogs represent exceptional models for defining causality, understanding progression, and developing new treatments for lymphoma in comparatively brief windows of time. Unique advantages of canine models include (1) spontaneous disease occurring without an isogenic background or genetic engineering ; (2) chronology of disease adapted to lifespan, (3) shared environment and societal status that allows dogs to be treated as "patients," while at the same time being able to ethically explore translational innovations that are not possible in human subjects; and (4) organization of dogs into breeds with relatively homogeneous genetic backgrounds and distinct predisposition for lymphomas. Here, we will review recent studies describing intrinsic and extrinsic factors that contribute to the pathogenesis of canine and human lymphomas, as well as newly developed tools that will enhance the fidelity of these models to improve diagnosis and develop new treatments.

AB - The term "lymphoma" describes a heterogeneous group of disorders involving monoclonal proliferation of malignant lymphocytes. As a group, lymphomas are among the most common tumors of dogs. Yet our enumeration and understanding of the many subtypes of lymphoma have been relatively slow, perhaps in part because for many years lymphoma was treated as a singular entity rather than a group of distinct diseases. The recognition that the full spectrum of lymphoid malignancies seen in humans also occurs in dogs, and that these tumors retain not only morphologic similarities and biological behavior but also synonymous driver molecular abnormalities, sets an ideal stage for dual-purpose research that can accelerate progress for these diseases in both species. Specifically, dogs represent exceptional models for defining causality, understanding progression, and developing new treatments for lymphoma in comparatively brief windows of time. Unique advantages of canine models include (1) spontaneous disease occurring without an isogenic background or genetic engineering ; (2) chronology of disease adapted to lifespan, (3) shared environment and societal status that allows dogs to be treated as "patients," while at the same time being able to ethically explore translational innovations that are not possible in human subjects; and (4) organization of dogs into breeds with relatively homogeneous genetic backgrounds and distinct predisposition for lymphomas. Here, we will review recent studies describing intrinsic and extrinsic factors that contribute to the pathogenesis of canine and human lymphomas, as well as newly developed tools that will enhance the fidelity of these models to improve diagnosis and develop new treatments.

UR - http://www.scopus.com/inward/record.url?scp=84900520514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900520514&partnerID=8YFLogxK

U2 - 10.1016/j.vetimm.2014.02.016

DO - 10.1016/j.vetimm.2014.02.016

M3 - Article

VL - 159

SP - 192

EP - 201

JO - Veterinary Immunology and Immunopathology

JF - Veterinary Immunology and Immunopathology

SN - 0165-2427

IS - 3-4

ER -